Market Price

22.20 

-0.90 -3.9%

as of Mar 03 '21

52 Week Range:

22.11 30.82


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 4.47
growth rate
Earnings BIT -66.09
-47.25
12.07
growth rate 0.0% 100.0%
ROA -6.59
-6.28
-5.63
growth rate 0.0% 0.0%
ROE -20.52
-20.73
-17.50
growth rate 0.0% 0.0%
ROIC -8.00
-7.64
-6.89
growth rate 0.0% 0.0%
Cur. Ratio 0.67
0.63
0.76
growth rate -6.0% 20.6%
Quick Ratio 0.56
0.55
0.63
growth rate -1.8% 14.6%
Leverage 3.11
3.53
2.79
growth rate 13.5% -21.0%
Balance Sheet Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 317.81
331.30
333.86
751.45
growth rate 4.2% 0.8% 125.1%
Acct.Payable 60.76
38.42
26.46
82.04
growth rate -36.8% -31.1% 210.1%
Cur.Assets 443.91
408.61
493.08
1,328.01
growth rate -8.0% 20.7% 169.3%
Total Assets 4,005.11
3,709.67
3,791.37
15,197.34
growth rate -7.4% 2.2% 300.8%
Cash 53.19
25.58
76.13
257.73
growth rate -51.9% 197.7% 238.5%
Cur.Liabilities 661.07
643.71
651.00
1,569.77
growth rate -2.6% 1.1% 141.1%
Liabilities 2,719.01
2,659.07
2,430.96
5,603.37
growth rate -2.2% -8.6% 130.5%
LT Debt 1,967.74
1,930.18
1,631.39
growth rate -1.9% -15.5%
Equity 1,286.11
1,050.61
1,360.41
9,593.97
growth rate -18.3% 29.5% 605.2%
Common Shares 305.00
305.00
274.00
growth rate 0.0% -10.2%
Cash Flow Statement Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 37.80
45.41
69.84
growth rate 20.1% 53.8%
Cash From OA 6.67
-26.10
117.58
263.50
growth rate -100.0% 100.0% 124.1%
FCF per Share 0.02
growth rate
Sale Purchase of Stock 1.57
1.58
7,558.77
growth rate 0.5% 477,698.6%
FCF -31.00
-72.00
45.00
growth rate 0.0% 100.0%
Income Statement Dec '17 Dec '18 Dec '19 Dec '20
Sales 917.63
968.47
974.35
1,254.05
growth rate 5.5% 0.6% 28.7%
Op.Income -66.09
-47.25
12.07
growth rate 0.0% 100.0%
IBT -285.22
-236.51
-200.78
-109.11
growth rate 0.0% 0.0% 0.0%
Net Income -263.93
-242.16
-210.98
-106.31
growth rate 0.0% 0.0% 0.0%
EPS -0.86
-0.79
-0.77
growth rate 0.0% 0.0%
Gross Profit 523.42
571.97
627.84
growth rate 9.3% 9.8%
R&D 0.00
growth rate

Quarterly Statements

Item Name Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Earnings BIT 52.35
26.30
8.33
39.94
22.79
growth rate -49.8% -68.3% 379.6% -43.0%
Balance Sheet Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Acct.Receivable 227.00
333.86
343.18
279.16
238.64
growth rate 47.1% 2.8% -18.7% -14.5%
Acct.Payable 27.91
26.46
28.58
22.07
19.90
growth rate -5.2% 8.0% -22.8% -9.8%
Cur.Assets 361.27
493.08
728.25
960.09
944.25
growth rate 36.5% 47.7% 31.8% -1.7%
Total Assets 3,650.29
3,791.37
4,999.09
5,210.18
5,150.71
growth rate 3.9% 31.9% 4.2% -1.1%
Cash 88.81
76.13
308.02
608.52
601.08
growth rate -14.3% 304.6% 97.6% -1.2%
Inventory
growth rate
Cur.Liabilities 560.30
651.00
778.32
711.40
662.68
growth rate 16.2% 19.6% -8.6% -6.9%
Liabilities 2,277.79
2,430.96
2,905.97
2,827.60
2,792.41
growth rate 6.7% 19.5% -2.7% -1.2%
LT Debt 1,305.36
1,631.39
1,923.82
1,921.40
1,917.66
growth rate 25.0% 17.9% -0.1% -0.2%
Equity 1,372.51
1,360.41
2,093.13
2,382.59
2,358.30
growth rate -0.9% 53.9% 13.8% -1.0%
Common Shares 329.00
2,208.53
3,033.03
3,326.27
3,328.78
growth rate 571.3% 37.3% 9.7% 0.1%
Cash Flow Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Capital Expenditures 46.31
26.16
19.40
33.26
25.95
growth rate -43.5% -25.9% 71.5% -22.0%
Cash Dividends
growth rate
Cash From OA 112.49
5.09
46.11
61.46
20.46
growth rate -95.5% 805.5% 33.3% -66.7%
Sale Purchase of Stock 0.28
1.58
819.31
1,122.47
1,122.59
growth rate 469.1% 51,689.2% 37.0% 0.0%
FCF 66.18
-21.06
26.71
28.20
-5.49
growth rate -100.0% 100.0% 5.6% -100.0%
Income Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Sales 243.00
255.01
240.59
273.50
284.36
growth rate 4.9% -5.7% 13.7% 4.0%
Op.Income 35.84
26.30
8.33
39.94
22.79
growth rate -26.6% -68.3% 379.6% -43.0%
IBT 12.48
-80.18
-59.25
-6.88
-32.91
growth rate -100.0% 0.0% 0.0% 0.0%
Net Income -126.19
-84.79
-74.00
-1.49
-37.23
growth rate 0.0% 0.0% 0.0% 0.0%
Gross Profit 155.88
172.52
158.19
182.64
192.56
growth rate 10.7% -8.3% 15.5% 5.4%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (55.39)

YOY Growth Grade:

E (22.05)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is undefined, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE
EPS / Growth 21.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 21.3% 35.7% 60.7%
Future PE 0.01 0.01 40.44
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT

Graham Number:

Current EPS is undefined, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.